Vaccines

December 11, 2017

We are going to face important challenges in public health and we need to improve the collaboration between scientists and policy-makers. Walter Ricciardi, President of the Italian National Institute of Health, explains why science-in-society is not just a slogan but a key perspective for citizens, scientists, healthcare workers and politicians.

Catharina de Kat, Communications, Web and Information Officer
Vaccine-preventable Diseases and Immunization

Bulgaria has a long immunization experience. Immunizations against tuberculosis, polio, diphtheria, pertussis, tetanus, measles, mumps, rubella, and hepatitis B have been mandatory for decades as well as recently introduced immunizations against pneumococcal diseases and Haemophilus infl.b infections too. Additionally, HPV vaccine was intensively introduced as recommended for 12-year old girls within a national vaccination campaign for prevention of HPV - caused cancers.

Emerging infectious diseases have a potential for great harm, spreading unchecked in naïve populations, usually poorly prepared to deal with the new threat. The devastating effect of infectious diseases is most strongly felt in low income countries, where the health infrastructure and preparedness plans are at best insufficient.

Persons over the age of 65 have a higher risk for severe influenza-related complications and have the highest risk of mortality from influenza. Vaccination of older persons have traditionally been the main focus of influenza vaccine policy, and while vaccines are not as efficient in this population as in younger adults, it still remains the most effective public health tool to protect against influenza (WHO 2012). Vaccination recommendations vary slightly between countries in Europe, however almost all cover older people as a specific target group (Endrich et al 2009).

Wednesday, April 26, 2017 (All day)

Members of the ASSET projects will present the results of the citizen consultation that took place in eight countries on September 2016 at the European Parliament. Such an event is part of the science-in-society approach performed by the project within the framework of Research and Innovation related to pandemic preparedness. ASSET citizen consultation is an innovative method of engaging citizens on complex issues, providing them with information before asking questions.

American Academy of Pediatrics. 2013 April. Vaccine Safety: Examine the Evidence.

The safety an​d effectiveness of vaccines​ are under constant study. ​Over the past decade, questions have been raised regarding a relationship between autism and vaccines. Along with general safety concerns, parents have wondered about:

Topic: 

Nyhan B, Reifler J, Richey S, Freed GL. Pediatrics. April, 2014.

Objectives: To test the effectiveness of messages designed to reduce vaccine misperceptions and increase vaccination rates for measles-mumps-rubella (MMR).

Topic: 
Subscribe to Vaccines

MMLAP and other EU Projects

Health system analysis to support capacity development in response to the threat of pandemic influenza in Asia
Making society an active participant in water adaptation to global change
Public Participation in Developing a Common Framework for Assessment and Management of Sustainable Innovation
Engaging all of Europe in shaping a desirable and sustainable future
Expect the unexpected and know how to respond
Driving innovation in crisis management for European resilience
Effective communication in outbreak management: development of an evidence-based tool for Europe
Solutions to improve CBRNe resilience
Network for Communicable Disease Control in Southern Europe and Mediterranean Countries
Developing the framework for an epidemic forecast infrastructure
Strengthening of the national surveillance system for communicable diseases
Surveillance of vaccine preventable hepatitis
European monitoring of excess mortality for public health action
European network for highly infectious disease
Dedicated surveillance network for surveillance and control of vaccine preventable diseases in the EU
Modelling the spread of pandemic influenza and strategies for its containment and mitigation
Cost-effectiveness assessment of european influenza human pandemic alert and response strategies
Bridging the gap between science, stakeholders and policy makers
Promotion of immunization for health professionals in Europe
Towards inclusive research programming for sustainable food innovations
Addressing chronic diseases and healthy ageing across the life cycle
Medical ecosystem – personalized event-based surveillance
Studying the many and varied economic, social, legal and ethical aspects of the recent developments on the Internet, and their consequences for the individual and society at large
Get involved in the responsible marine research and innovation
Knowledge-based policy-making on issues involving science, technology and innovation, mainly based upon the practices in Parliamentary Technology Assessment
Assessment of the current pandemic preparedness and response tools, systems and practice at national, EU and global level in priority areas
Analysis of innovative public engagement tools and instruments for dynamic governance in the field of Science in Society
Public Engagement with Research And Research Engagement with Society
Computing Veracity – the Fourth Challenge of Big Data
Providing infrastructure, co-ordination and integration of existing clinical research networks on epidemics and pandemics
Promote vaccinations among migrant population in Europe
Creating mechanisms for effectively tackling the scientific and technology related challenges faced by society
Improve the quality of indoor air, keeping it free from radon
Improving respect of ethics principles and laws in research and innovation, in line with the evolution of technologies and societal concerns
Investigating how cities in the West securitise against global pandemics
Creating a structured dialogue and mutual learning with citizens and urban actors by setting up National Networks in 10 countries across Europe
Identifying how children can be change agents in the Science and Society relationship
Establishing an open dialogue between stakeholders concerning synthetic biology’s potential benefits and risks
Transparent communication in Epidemics: Learning Lessons from experience, delivering effective Messages, providing Evidence